LOGO
Contact

A Biometric Enrollment Platform Built for Zero Duplicate Identity

Delivered a biometric clinical trial enrollment platform using fingerprint de-duplication, role-based access, and real time Power BI dashboards for UNC's Malawi research hub.

UNC School of Medicine - Biometric enrollment platform

Client profile

UNC School of Medicine operates a major international clinical research hub in Malawi, processing over 5,000 patient enrolments monthly across numerous active clinical trials and studies.

Industry type

Healthcare/Education 

Employees

5,466+

Country

USA

Project overview

UNC’s Malawi research hub operates without access to formal national ID infrastructure. This absence created a serious data integrity risk across every active clinical trial. 

Patients were being enrolled multiple times, sometimes across different studies, sometimes across repeat visits to the same one. The consequences extended beyond inconvenience: compromised research data, duplicate compensation payments, and compliance gaps with international research sponsors. Manual tracking had already proven error-prone, and off-the-shelf tools tried previously were too rigid for this environment. UNC needed a purpose-built system capable of working reliably at scale, across multiple stakeholder types, in a genuinely low-infrastructure setting. SHALIGRAM was brought in to architect that system from the ground up. 

The result was a full biometric screening platform built specifically for this context. It now anchors data integrity across UNC’s international research operations. 

Technical challenges

In the absence of national identification infrastructure, UNC faced a data integrity challenge with direct financial and scientific implications. Any proposed solution required proven capability at clinical scale. 

  • Patients lacked standardized national IDs, passports, or driver’s licenses to verify identity reliably. 
  • Duplicate enrolments across studies and visits compromised the validity of active clinical trial data. 
  • Duplicate compensation payments were being issued to the same patients repeatedly and unknowingly. 
  • Manual visit tracking was inherently error-prone and could not scale to 5,000 monthly patients. 
  • Previously tried off-the-shelf tools proved too rigid and unreliable for this specific research context. 
  • The platform needed distinct access levels for screeners, auditors, data managers, and super admins. 

Our solution

SHALIGRAM architected a full biometric screening platform built on .NET Core, Angular, SQL Server, and Power BI. Every component was designed around UNC’s actual research operations. 

Add update biometric enrollment platform
Add update q1 biometric enrollment platform
Role rights biometric enrollment platform
Scanner biometric enrollment platform

Real-time fingerprint verification

Integrated Secugen Hamster Pro 20 fingerprint hardware to enable real-time identity verification, checking every new patient registration directly against the entire existing database before any enrollment could ever be confirmed as valid or approved by staff.

Centralized patient records

Centralized complete patient visit histories across all research sites, with direct linkage to specific studies and trials, giving staff a single, reliable, always up-to-date source of truth for every enrolled patient record and complete visit history.

Role-based access control

Implemented strict role-based access control so that on-site screeners, auditors, data managers, and super admins each see exactly the information relevant to their role, and nothing beyond what they are formally authorized to access at any time.

Live compliance dashboards

Built dynamic, easy-to-read Power BI dashboards that give administrators and compliance teams real-time visibility into registration volumes, individual site performance, and flagged anomalies requiring immediate follow-up or further investigation by clinical or research staff on the ground.

Automated audit trails

Automated audit trail generation for every single patient interaction, satisfying international sponsor compliance requirements without ever requiring manual documentation, tedious cross-referencing, or any additional administrative overhead and manual work from clinical or research staff on-site.

Built for global scale

Designed the entire platform for scalability from the very outset, deliberately enabling expansion beyond Malawi to any additional international site where UNC conducts clinical research now, or plans to at any point in the future.

What our client achieved from our solutions

99% reduction in duplicates

Duplicate patient enrolments dropped by a remarkable 99%, directly protecting the scientific validity of active clinical trial data across every research site UNC currently operates within Malawi and any additional international locations worldwide it maintains.

Improved data integrity

Data integrity across all active clinical trials improved immediately and measurably, giving researchers and international sponsors renewed confidence in the ongoing accuracy and reliability of enrollment and visit records going forward across every single study.

Eliminated duplicate payments

Duplicate compensation payments were eliminated entirely and permanently, removing a recurring financial risk that had previously gone entirely undetected across multiple studies and repeat patient visits over an extended period of time and study cycles.

Real-time registration

Registration that once required lengthy, error-prone manual cross-checking now happens in real time at the exact point of fingerprint scan, dramatically reducing processing time for every incoming patient across all active research sites and studies.

Automatic compliance audit trails

Audit trails became fully automatic and consistently reliable, satisfying sponsor compliance requirements without any manual documentation whatsoever and giving compliance teams instant visibility into every single recorded patient interaction across all active trials and sites.

Scalable global infrastructure

UNC gained a platform genuinely built for scale from day one, fully capable of expanding to additional international research sites as their clinical trial operations continue to grow steadily well beyond Malawi over the coming years.